Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz, A Ruggeri… - Journal of hematology & …, 2021 - Springer
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than …
The best donor option for acute myeloid leukemia (AML) patients lacking an HLA‐matched
donor has remained intensively debated. We herein report the results of a large …
donor has remained intensively debated. We herein report the results of a large …
Effect of graft-versus-host disease on post-transplantation outcomes following single cord blood transplantation compared with haploidentical transplantation with post …
T Konuma, K Matsuda, Y Shimomura, S Tanoue… - … and Cellular Therapy, 2023 - Elsevier
The possibility that HLA mismatches could reduce relapse after alternative HLA-mismatched
allogeneic hematopoietic cell transplantation (HCT) is an attractive concept for treating acute …
allogeneic hematopoietic cell transplantation (HCT) is an attractive concept for treating acute …
Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia
Y Shimomura, T Sobue, S Hirabayashi, T Kondo… - Leukemia, 2022 - nature.com
Cord blood transplantation (CBT) is an alternative donor transplantation method and has the
advantages of rapid availability and the possibility of inducing a more potent graft-versus …
advantages of rapid availability and the possibility of inducing a more potent graft-versus …
Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non‐remission acute myeloid leukaemia: A …
K Matsuda, T Konuma, K Fuse… - British Journal of …, 2023 - Wiley Online Library
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for some patients with acute myeloid leukaemia (AML) who are refractory to …
treatment for some patients with acute myeloid leukaemia (AML) who are refractory to …
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Outcomes after unmanipulated haploidentical stem cell transplantation (Haplo) and after
unrelated cord blood transplantation (UCBT) are encouraging and have become alternative …
unrelated cord blood transplantation (UCBT) are encouraging and have become alternative …
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male …
Background In the setting of allogeneic human leukocyte antigen (HLA)-matched bone
marrow transplantation, transplanting male patients with grafts from female donors has been …
marrow transplantation, transplanting male patients with grafts from female donors has been …
Single cord blood transplantation versus unmanipulated haploidentical transplantation for adults with acute myeloid leukemia in complete remission
T Konuma, J Kanda, S Yamasaki, K Harada… - … and Cellular Therapy, 2021 - Elsevier
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative post-remission
therapy for adult patients with acute myeloid leukemia (AML) in complete remission (CR) …
therapy for adult patients with acute myeloid leukemia (AML) in complete remission (CR) …
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study …
J Sanz, JE Galimard, M Labopin, B Afanasyev… - Journal of hematology & …, 2020 - Springer
Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …
preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting …
Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) …
In the evolution of haploidentical hematopoietic stem cell transplantation (haplo-HSCT), In
vivo T-cell modulation with concomitant use of anti-thymocyte globulin (ATG) and high-dose …
vivo T-cell modulation with concomitant use of anti-thymocyte globulin (ATG) and high-dose …